Paul Savina

In Vitro Investigations into the Roles of Drug Transporters and Metabolizing Enzymes in the Disposition and Drug Interactions of Dolutegravir, a HIV Integrase Inhibitor

Melinda J. Reese, Paul Savina, Grant T. Generaux et al. · Drug Metabolism and Disposition · 2012 · 246 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans

Stephen Castellino, Lee Moss, David S. Wagner et al. · Antimicrobial Agents and Chemotherapy · 2013 · 138 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

A sensitive HPLC–MS/MS method for the determination of dolutegravir in human plasma

Chantelle Bennetto‐Hood, Glenn Tabolt, Paul Savina et al. · Journal of Chromatography B · 2013 · 74 citations

Pharmacy, Pharmaceutical Analysis, Pharmacokinetics +11

5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profile

Susan M. Daluge, D. J. M. Purifoy, Paul Savina et al. · Antimicrobial Agents and Chemotherapy · 1994 · 60 citations · Full text

Medicine, Infectious Diseases, Pharmacology +13

Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment

S Weller, Julie Borland, Shuguang Chen et al. · European Journal of Clinical Pharmacology · 2013 · 59 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17